Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine.

Turubanova VD, Balalaeva IV, Mishchenko TA, Catanzaro E, Alzeibak R, Peskova NN, Efimova I, Bachert C, Mitroshina EV, Krysko O, Vedunova MV, Krysko DV.

J Immunother Cancer. 2019 Dec 16;7(1):350. doi: 10.1186/s40425-019-0826-3.

2.

Water-Soluble Chlorin/Arylaminoquinazoline Conjugate for Photodynamic and Targeted Therapy.

Otvagin VF, Kuzmina NS, Krylova LV, Volovetsky AB, Nyuchev AV, Gavryushin AE, Meshkov IN, Gorbunova YG, Romanenko YV, Koifman OI, Balalaeva IV, Fedorov AY.

J Med Chem. 2019 Dec 26;62(24):11182-11193. doi: 10.1021/acs.jmedchem.9b01294. Epub 2019 Dec 13.

PMID:
31782925
3.

Effect of novel porphyrazine photosensitizers on normal and tumor brain cells.

Mishchenko TA, Turubanova VD, Mitroshina EV, Alzeibak R, Peskova NN, Lermontova SA, Klapshina LG, Balalaeva IV, Vedunova MV, Krysko DV.

J Biophotonics. 2020 Jan;13(1):e201960077. doi: 10.1002/jbio.201960077. Epub 2019 Oct 17.

PMID:
31595675
4.

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model.

Sokolova EA, Shilova ON, Kiseleva DV, Schulga AA, Balalaeva IV, Deyev SM.

Int J Mol Sci. 2019 May 15;20(10). pii: E2399. doi: 10.3390/ijms20102399.

5.

Preclinical Study of Biofunctional Polymer-Coated Upconversion Nanoparticles.

Guryev EL, Shilyagina NY, Kostyuk AB, Sencha LM, Balalaeva IV, Vodeneev VA, Kutova OM, Lyubeshkin AV, Yakubovskaya RI, Pankratov AA, Ingel FI, Novik TS, Deyev SM, Ermilov SA, Zvyagin AV.

Toxicol Sci. 2019 Jul 1;170(1):123-132. doi: 10.1093/toxsci/kfz086.

PMID:
30985900
6.

Low-level laser therapy as a modifier of erythrocytes morphokinetic parameters in hyperadrenalinemia.

Deryugina AV, Ivashchenko MN, Ignatiev PS, Balalaeva IV, Samodelkin AG.

Lasers Med Sci. 2019 Oct;34(8):1603-1612. doi: 10.1007/s10103-019-02755-y. Epub 2019 Mar 4.

PMID:
30834462
7.

Targeted Delivery to Tumors: Multidirectional Strategies to Improve Treatment Efficiency.

Kutova OM, Guryev EL, Sokolova EA, Alzeibak R, Balalaeva IV.

Cancers (Basel). 2019 Jan 10;11(1). pii: E68. doi: 10.3390/cancers11010068. Review.

8.

Photobiological properties of phthalocyanine photosensitizers Photosens, Holosens and Phthalosens: A comparative in vitro analysis.

Brilkina AA, Dubasova LV, Sergeeva EA, Pospelov AJ, Shilyagina NY, Shakhova NM, Balalaeva IV.

J Photochem Photobiol B. 2019 Feb;191:128-134. doi: 10.1016/j.jphotobiol.2018.12.020. Epub 2018 Dec 27.

PMID:
30616037
9.

3D in vitro models of tumors expressing EGFR family receptors: a potent tool for studying receptor biology and targeted drug development.

Sokolova EA, Vodeneev VA, Deyev SM, Balalaeva IV.

Drug Discov Today. 2019 Jan;24(1):99-111. doi: 10.1016/j.drudis.2018.09.003. Epub 2018 Sep 8. Review.

PMID:
30205170
10.

Radioactive (90Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.

Guryev EL, Volodina NO, Shilyagina NY, Gudkov SV, Balalaeva IV, Volovetskiy AB, Lyubeshkin AV, Sen' AV, Ermilov SA, Vodeneev VA, Petrov RV, Zvyagin AV, Alferov ZI, Deyev SM.

Proc Natl Acad Sci U S A. 2018 Sep 25;115(39):9690-9695. doi: 10.1073/pnas.1809258115. Epub 2018 Sep 7.

11.

Liposomal Form of Tetra(Aryl)Tetracyanoporphyrazine: Physical Properties and Photodynamic Activity In Vitro.

Yudintsev AV, Shilyagina NY, Dyakova DV, Lermontova SA, Klapshina LG, Guryev EL, Balalaeva IV, Vodeneev VA.

J Fluoresc. 2018 Mar;28(2):513-522. doi: 10.1007/s10895-018-2212-9. Epub 2018 Jan 26.

PMID:
29374365
12.

Synthesis and biological evaluation of new water-soluble photoactive chlorin conjugate for targeted delivery.

Otvagin VF, Nyuchev AV, Kuzmina NS, Grishin ID, Gavryushin AE, Romanenko YV, Koifman OI, Belykh DV, Peskova NN, Shilyagina NY, Balalaeva IV, Fedorov AY.

Eur J Med Chem. 2018 Jan 20;144:740-750. doi: 10.1016/j.ejmech.2017.12.062. Epub 2017 Dec 19.

PMID:
29291441
13.

Pharmacokinetics of Chlorin e₆-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma.

Volovetsky AB, Sukhov VS, Balalaeva IV, Dudenkova VV, Shilyagina NY, Feofanov АV, Efremenko AV, Grin MA, Mironov AF, Sivaev IB, Bregadze VI, Maslennikova AV.

Int J Mol Sci. 2017 Nov 28;18(12). pii: E2556. doi: 10.3390/ijms18122556.

14.

Monitoring of hydrogen peroxide production under photodynamic treatment using protein sensor HyPer.

Brilkina AA, Peskova NN, Dudenkova VV, Gorokhova AA, Sokolova EA, Balalaeva IV.

J Photochem Photobiol B. 2018 Jan;178:296-301. doi: 10.1016/j.jphotobiol.2017.11.020. Epub 2017 Nov 17.

PMID:
29175603
15.

In vivo multimodal tumor imaging and photodynamic therapy with novel theranostic agents based on the porphyrazine framework-chelated gadolinium (III) cation.

Yuzhakova DV, Lermontova SA, Grigoryev IS, Muravieva MS, Gavrina AI, Shirmanova MV, Balalaeva IV, Klapshina LG, Zagaynova EV.

Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3120-3130. doi: 10.1016/j.bbagen.2017.09.004. Epub 2017 Sep 13.

PMID:
28916141
16.

Effective delivery of porphyrazine photosensitizers to cancer cells by polymer brush nanocontainers.

Shilyagina NY, Peskova NN, Lermontova SA, Brilkina AA, Vodeneev VA, Yakimansky AV, Klapshina LG, Balalaeva IV.

J Biophotonics. 2017 Sep;10(9):1189-1197. doi: 10.1002/jbio.201600212. Epub 2016 Nov 28.

PMID:
27892657
17.

Passive and active targeting of quantum dots for whole-body fluorescence imaging of breast cancer xenografts.

Balalaeva IV, Zdobnova TA, Krutova IV, Brilkina AA, Lebedenko EN, Deyev SM.

J Biophotonics. 2012 Nov;5(11-12):860-7. doi: 10.1002/jbio.201200080. Epub 2012 Aug 8.

PMID:
22887708
18.

Novel PEG-organized biocompatible fluorescent nanoparticles doped with an ytterbium cyanoporphyrazine complex for biophotonic applications.

Klapshina LG, Douglas WE, Grigoryev IS, Ladilina EY, Shirmanova MV, Mysyagin SA, Balalaeva IV, Zagaynova EV.

Chem Commun (Camb). 2010 Nov 28;46(44):8398-400. doi: 10.1039/c0cc02842h. Epub 2010 Oct 7.

PMID:
20927471
19.

Fluorescent immunolabeling of cancer cells by quantum dots and antibody scFv fragment.

Zdobnova TA, Dorofeev SG, Tananaev PN, Vasiliev RB, Balandin TG, Edelweiss EF, Stremovskiy OA, Balalaeva IV, Turchin IV, Lebedenko EN, Zlomanov VP, Deyev SM.

J Biomed Opt. 2009 Mar-Apr;14(2):021004. doi: 10.1117/1.3122775.

Supplemental Content

Loading ...
Support Center